The portfolio maintains a cost advantage over competitors, priced within the second-lowest fee quintile among peers.
Driehaus Small Cap Growth Investor DVSMX
- NAV / 1-Day Return 22.95 / +0.22 %
- Total Assets 912.0 Mil
-
Adj. Expense Ratio
- Expense Ratio 0.970%
- Distribution Fee Level Below Average
- Share Class Type No Load
- Category Small Growth
- Investment Style Small Growth
- Min. Initial Investment 10,000
- Status Open
- TTM Yield 0.31%
- Turnover 154%
USD | NAV as of Sep 28, 2024 | 1-Day Return as of Sep 28, 2024, 12:17 AM GMT+0
Morningstar’s Analysis DVSMX
Will DVSMX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 18.8
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
Northern Institutional US Govt Sel | 4.40 | 37.1 Mil | Cash and Equivalents |
Crinetics Pharmaceuticals Inc | 2.60 | 21.9 Mil | Healthcare |
TransMedics Group Inc | 2.56 | 21.6 Mil | Healthcare |
FTAI Aviation Ltd | 1.98 | 16.6 Mil | Industrials |
Axon Enterprise Inc | 1.88 | 15.9 Mil | Industrials |
Vaxcyte Inc Ordinary Shares | 1.85 | 15.6 Mil | Healthcare |
Cameco Corp | 1.71 | 14.4 Mil | Energy |
Modine Manufacturing Co | 1.65 | 13.9 Mil | Consumer Cyclical |
Xenon Pharmaceuticals Inc | 1.59 | 13.4 Mil | Healthcare |
Glaukos Corp | 1.58 | 13.3 Mil | Healthcare |